Report launched in 2012, the latest issued 2015. 3, 4 This report includes updates on staging and management guidelines on sitespecific gynecological cancer.
A second staging system, the Tumor, Node, and Metastasis (TNM) classification, was adopted by the International Union Against
Cancer in 1966 and the American Joint Commission on Cancer in 1976. 5 Although the TNM classification has been widely adopted for staging most cancers, the FIGO classification is still the most commonly used staging system for female genital cancers. Several modifications to the FIGO classification and staging of cervical cancer have been adopted, and the rationale for keeping clinical staging instead of surgical staging is described in detail by Pecorelli.
1 The rationale for the clinical approach is that 85%-90% of all new cervical cancer cases are diagnosed in low-income regions, 3, 4, 6 where both screening and vaccination is sparse. 7 Therefore, the majority of women with cervical cancer will be staged according to the FIGO guideline and thereby ensure global comparability of outcomes.
According to the latest FIGO staging guidelines, examination under anesthesia, cystoscopy, sigmoidoscopy, and intravenous pyelography are no longer mandatory and radiological tumor volume as well as parametrial invasion should be recorded separately.
In the Nordic countries, the annual incidence of new cervical 
| MATERIAL AND ME THODS

| Ethical approval
No ethical approval was required for this survey as no personally identifiable information was collected.
| RE SULTS
Physicians from a total of 19 of 22 (86%) Nordic Gynecological
Oncology Centers completed the survey. The response rate was 100% in Denmark, Finland, and Iceland, 86% (6 of 7) in Sweden, and 50% (2 of 4) in Norway. The median (range) number of new cervical cancer cases treated annually at each center was 32 (15-120). Two to five surgeons performed the radical hysterectomy in each institution. Table 1 shows the number and type of routinely employed imaging modalities in the diagnostic work-up of newly diagnosed cervical cancer at the Nordic Gynecological Oncology Centers. After clinical staging 3 17
Surgical procedure (n = 18 a )
Robotic-assisted radical hysterectomy 13 72
Robotic-assisted, laparoscopic and abdominal radical hysterectomy
28
Sentinel lymph node (SLN) procedure (n = 18 a )
Established practice 3 17
In protocolled trial 5 28
Established practice and in protocolled trial
Not performed 9 50
CT, computed tomography; MRI, magnetic resonance imaging; PET-CT, positron emission tomography-computed tomography; US, ultrasound. a One center performed oncological treatment alone. The surgical procedures were reported by 18 centers (Table 1) .
TA B L E 1
Robotic-assisted radical hysterectomy was performed in all centers.
In 72% (13 of 18), this was reported as the preferred method, and the remaining centers reported performing a combination of roboticassisted, laparoscopic, and abdominal radical hysterectomy. In three (17%) centers, the SLN procedure was reported as established prac- 
| D ISCUSS I ON
The majority of Nordic Gynecological Oncology Centers reported that the results from diagnostic imaging had an impact on the re- we would like to encourage that in the future, FIGO staging of cervical cancer will be either surgically staged like all other cancers of the genital tract 1 or clinical, imaging and/or surgical, dependent on the resources available. The NSGO Surgical Subcommittee has the intention to collaborate on a prospective protocol to report the work-up done in relation to staging and pretreatment planning plus the given treatment.
The aim is also to promote more uniform management of women with cervical cancer in the Nordic countries in the future.
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